Leading Specialty Pharmaceutical Company Selects IVR Clinical Concepts Inc. (IVRCC)

SARATOGA SPRINGS, N.Y. - May 15, 2015 - PRLog -- An innovative global specialty pharmaceutical company, focused on the development and commercialization of proprietary medicines to meet major unmet medical needs of patients, has selected IVRCC  to collaborate on a new safety and pharmacokinetic study.  Choosing IVRCC’s technology reflects their commitment to agile and powerful interactive data capture technologies for development of therapies to prevent and treat a wide range of disease states.

To include important patient reported outcomes contributing to primary and secondary efficacy endpoints, the company specifically sought technology that would be easy to learn and intuitive for subjects to use on a daily basis.  IVRCC’s Voice and Web systems, will collect and manage subject feedback daily, and will store and report on data collected in real-time, to boost clinicians ability to respond to patients’ needs throughout the study.

“IVRCC’s customized applications provide the flexibility to help patients easily and comprehensively report both objective and subjective information about their daily symptoms and therapeutically related events,” says Nancy Hudak, Business Development Manager. “Our programs are built to be extremely intuitive and user friendly, and are offered in familiar interchangeable modes, via voice phone and web accessible PC and mobile smartphone and tablet (Apple and Android) platforms, to facilitate complete and accurate reporting from the subjects.  We are very excited to be working with this biopharmaceutical leader to support development of medicines with a range of therapeutic applications,” adds Hudak.